EligibleTrials

Symplicity China Study

Recruiting · NCT07081243 · Observational (researchers observe without assigning treatment) · Lead sponsor: Medtronic Vascular

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

Symplicity Spyral Renal Denervation System

What this trial is about

The Symplicity China study will evaluate the real-world long-term safety, efficacy, and durability of the Symplicity Spyral system in a population of approximately 500 renal denervation treated subjects with up to 36 months of follow up.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.